<DOC>
	<DOCNO>NCT03042585</DOCNO>
	<brief_summary>Most participant relapse refractory non-Hodgkin 's lymphoma receive autologous transplant likely suffer relapse standard myeloablative preparative regimen unable produce cure . The majority participant stem cell donor available , frail undergo allogeneic transplant , refuse allograft . Historically participant high risk non-Hodgkin 's lymphoma poor outcome . To take advantage low transplant relate mortality associate autologous transplantation , investigator propose modify preparative regimen make effective without increase toxicity . By increase dose radiation administer protective growth factor palifermin ( Kepivance ) , investigator hope decrease risk relapse without increase transplant relate mortality . Three prospective randomize trial study different radiation scheme part TBI cytoxan preparative regimen prior allogeneic transplantation patient AML CML . As group trial show high dos TBI old study decrease risk relapse expense VOD , GVHD , CMV . Three retrospective study also postulate high dose radiation lead less risk relapse .</brief_summary>
	<brief_title>Autologous Transplant Using Dose-Escalated Total Body Irradiation &amp; Cyclophosphamide &amp; Palifermin NHL</brief_title>
	<detailed_description>This non-randomized , open-label phase I trial participant non-Hodgkin 's lymphoma . The preparative regimen follow : Day -10 ( prior transplant ) Palifermin treatment prevent mouth sore Day -9 Palifermin treatment prevent mouth sore Day -8 Palifermin treatment prevent mouth sore Day -7 Total Body Irradiation twice day Day -6 Total Body Irradiation twice day Day -5 Total Body Irradiation twice day Day -4 Total Body Irradiation twice day Day -3 Cytoxan chemotherapy infusion Day -2 Cytoxan chemotherapy infusion Day -1 Day rest Day 0 Stem cell infusion ( bone marrow transplant ) , Palifermin treatment prevent mouth sores G-CSF give daily stem cell take hold ( engraftment ) occurs . Day +1 Palifermin treatment prevent mouth sore Day +2 Palifermin treatment prevent mouth sore</detailed_description>
	<mesh_term>Lymphoma</mesh_term>
	<mesh_term>Lymphoma , Non-Hodgkin</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Age 18 year age old Participants schedule undergo autologous stem cell transplantation relapse refractory nonHodgkin 's Lymphoma le partial remission salvage therapy . Participants schedule undergo autologous stem cell transplantation relapse refractory nonHodgkin 's Lymphoma site disease 2 cm great pretransplant imaging . Participants must performance status ( PS ) 01 . Participants must acceptable kidney function . Acceptable pulmonary function test lung . Acceptable liver function test . Participants must cutaneous Tcell , mantle cell , lymphoblastic lymphoma . Participants must prior peripheral blood marrow transplantation . Participants must prior radiation . Participants must significant history uncontrolled cardiac disease ; example , uncontrolled hypertension , unstable angina , recent myocardial infarction ( within prior 6 month ) , uncontrolled congestive heart failure , cardiomyopathy decrease ejection fraction . Participants must active bacterial , fungal , viral infection .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>BMT</keyword>
	<keyword>NHL</keyword>
	<keyword>Non-Hodgkin Lymphoma</keyword>
	<keyword>Relapsed Non-Hodgkin Lymphoma</keyword>
	<keyword>Refractory Non-Hodgkin Lymphoma</keyword>
	<keyword>autologous stem cell transplantation</keyword>
</DOC>